Skip to main content

ScienceDex / Researcher record

Chen, Ridong

From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.

FY2018 NIH rank #2,677
  • Rising Star
  • Long-Funded
  • Diverse Portfolio

NIH Funding · FY2018

$2.1M
Full award amounts, FY2018
5
Records listing this PI
#2,677
By linked amount among FY2018 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$336,7451#18,402
2007$830,6973#8,161
2008$196,7451#30,506
2009$626,9312#13,983
2010$1,338,9073#5,805
2011$593,6292#13,157
2012$1,011,2382#6,880
2013$866,1142#7,709
2014$449,0182#16,848
2015$895,6893#7,844
2016$1,492,3573#4,099
2017$2,348,1063#2,053
2018$2,077,5765#2,677
2019$1,368,4513#5,434
2021$1,255,9752#6,918
2022$922,4761#10,872
2023$2,083,3422#3,540

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20061 record
  2. FY20073 records
  3. FY20081 record
  4. FY20092 records
  5. FY20103 records
  6. FY20112 records
  7. FY20122 records
  8. FY20132 records
  9. FY20142 records
  10. FY20153 records
  11. FY20163 records
  12. FY20173 records
  13. FY2018 · selected5 records
  14. FY20193 records
  15. FY20212 records
  16. FY20221 record
  17. FY20232 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Chen, Ridong. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2018 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2018 award records by amount

NIH award records listing Chen, Ridong as a PI. Multi-PI records show the full award amount for context.

  • 5R44HL135993-02R44Contact PI
    Antithrombotic Therapy with No Bleeding Risk for PCI
    $878.3K
    award amount
  • 1R43HL140699-01A1R43Contact PI
    Prevention of Post-MI Heart Failure with Immunomodulatory Therapy
    $337.6K
    award amount
  • 1R43CA228319-01R43Contact PI
    Synergistic Anti-tumor Efficacy of an Interleukin 2 Analog and PD-1 blockade
    $299.8K
    award amount
  • 1R43NS106850-01R43Contact PI
    Immunomodulatory Therapy for Neuropathic Pain
    $299.3K
    award amount
  • 5SB1NS060175-06SB1Contact PI
    Human Apyrase Therapy for Acute Ischemic Stroke
    $262.5K
    award amount

Award organization

Organizations that administered FY2018 awards listing Chen, Ridong as a PI.

FY2018 award administered by Apt Therapeutics, Inc. (IL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Apt Therapeutics, Inc.
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    Entered Top 50% Nationally
    Ranked #8161
  5. 2010
    $2M Cumulative Funding
  6. 2013
    $5M Cumulative Funding
  7. 2016
    Entered Top 25% Nationally
    Ranked #4099
  8. 2017
    $10M Cumulative Funding